Oxygen Extraction and Delivery in Elderly During Major Surgery

Sponsor
Karolinska Institutet (Other)
Overall Status
Completed
CT.gov ID
NCT03355118
Collaborator
(none)
20
1
4.2
4.8

Study Details

Study Description

Brief Summary

This clinical observational study investigates perioperative oxygen consumption and delivery in elderly patients undergoing major surgery. The primary objectives are to characterise the perioperative oxygen delivery, consumption and potential markers of oxygen debt. Secondary objective is to estimate the correlation between oxygen delivery/consumption and postoperative outcomes to guide the design of a future trial.

Condition or Disease Intervention/Treatment Phase
  • Other: General anaesthesia and major surgery

Detailed Description

Background Intra- and postoperative fluid therapy aims to achieve or maintain pre-specified thresholds of oxygen delivery/blood flow which can be accomplished by use of fluids with or without inotropic drugs. The used thresholds of oxygen delivery were suggested over 40 years ago, in considerably younger patients compared to the current patients. Update of the characteristics of perioperative oxygen delivery and consumption is reasonable in modern clinical settings.

Primary outcome:

relative changes of oxygen consumption induced by anaesthesia

Secondary outcomes:

relative changes of oxygen consumption and delivery during surgery and postoperatively, oxygen extraction ratio (measured and estimated), potential markers of oxygen debt frequency of in-hospital postoperative complications, mortality (30 Days)

Population:

Men and women ≥65 years undergoing major/complex surgical procedures, when intra-operative cardiovascular monitoring is justified according to clinical decision.

Intervention: no study related intervention, general anaesthesia and surgery according to clinical routine

Blinding: no blinding

Study size:

Pilot study 1: feasibility assessment of study protocol of intra-operative measurements (n= max 10) Pilot study 2: feasibility assessment of study protocol of postoperative measurements (n= max 10) Main study: 60 subjects (20+´40) Planned analysis of oxygen consumption after 20 monitored subjects

Study duration:
Duration of haemodynamic monitoring 24-36 hours Duration of observation of clinical outcomes:

7-10 days, mortality at 30 days postop.

Investigational events:

monitoring of oxygen consumption and delivery monitoring of postoperative clinical outcomes monitoring of markers of tissue injury

Assessments, Procedures and Schedule of Investigational Events:

Subjects are identified by the operation planning list and assessed for eligibility. The study information will be given verbal during the first hospital visit. Subjects who give written informed consent will be included in the study.

Measurements:

oxygen consumption by indirect calorimetry via face mask (in awake state) and via expiratory extension tube of anaesthesia machine (unconscious state) cardiac output monitoring via arterial line (LiDCO) blood samples: arterial and venous blood gase samples, Troponin-T urine samples: N-gal

Clinical outcomes:

Data collection from medical records on postoperative complications using the POMS (postoperative morbidity survey) screening survey at days 3,7 and 10. Postoperative mortality at day 30.

Study Design

Study Type:
Observational
Actual Enrollment :
20 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Exploring New Grounds in Physiology of the Elderly- Oxygen Extraction and Delivery During Anaesthesia and Major Surgery
Actual Study Start Date :
Nov 27, 2017
Actual Primary Completion Date :
Mar 23, 2018
Actual Study Completion Date :
Apr 4, 2018

Outcome Measures

Primary Outcome Measures

  1. oxygen consumption [prior to and 15 minutes after anaesthesia induction]

    change of oxygen consumption after anaesthesia induction

Secondary Outcome Measures

  1. oxygen consumption [perioperatively 0-36hrs]

    changes of oxygen consumption during surgery and postoperative recovery

  2. oxygen extraction ratio [perioperatively 0-36hrs]

    ratio between oxygen consumption and oxygen delivery

  3. oxygen extraction ratio: estimated and measured [perioperatively 0-36hrs]

    ratio between oxygen consumption and oxygen delivery estimated from blood gases and measured by indirect calorimetry and cardiac output monitoring

  4. C(v-a)pCO2/C(a-v)O2 [perioperatively 0-36hrs]

    Ratio: venoarterial pCO2 difference/arterio-venous oxygen content difference

  5. postoperative complications [postoperative days 3,5 and 10]

    postoperative complications described by Postoperative Morbidity Survey (8)

  6. mortality [postoperative days 30]

    postoperative mortality

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Men and women aged ≥65 years

  2. Major/complex surgery (BUPA AXA classification of surgical severity)

  3. Central and arterial venous catheterization for hemodynamic monitoring.

  4. Written informed consent

  5. Available research team for the measurements If two subjects are eligible the elder one will be chosen. If there are two subjects eligible of different gender and almost the same age, the subject with a gender that is underrepresented by two or more will be chosen. This is consistent with the purpose of including subjects with as high age as possible without interfering with recruitment.

Exclusion Criteria

  1. Concomitant medication with Lithium (interferes with calibration of the LiDCO monitor)

  2. Weight≤ 40 kg.

  3. Not possible to establish arterial or central venous line.

  4. Planned postoperative care at high-dependency unit (POP/IMA) <12hrs.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Karolinska University hospital Huddinge Stockholm Sweden 141 86

Sponsors and Collaborators

  • Karolinska Institutet

Investigators

  • Study Director: Erzsebet Bartha, MD PhD, Karolinska University Hospital Huddinge, Stockholm, Sweden
  • Principal Investigator: Julia Jakobsson, MD, Karolinska University Hospital Huddinge, Stockholm, Sweden

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sigridur Kalman, Professor, Senior Consultant, Karolinska Institutet
ClinicalTrials.gov Identifier:
NCT03355118
Other Study ID Numbers:
  • K2017-0373
  • 4-500/2017
First Posted:
Nov 28, 2017
Last Update Posted:
Jun 30, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 30, 2022